组织陈列-产品详情

home > TISSUE ARRAYS > Breast > FMG08013f

Type
- FFPE
- FROZEN TISSUE
Identity
Organ
- Liver
- Esophagus
- Ovary
- Stomach
- Lung
- Colon
- Rectum
- Kidney
- Breast
- Endometrium
- Uterus
- Bladder
- Pancreas
- Skin
- Penis
- Testis
- Soft_Tissue
- Bone/Cartilage
- Oral/Cavity
- Bone/Marrow
- Heart
- Spleen
- Head/Neck
- Vulva
- Melanoma
- Appendix
- Intestine
- Adrenal Gland
- Thymus
- Fallopian tube
- Mouse
- Fetus
- Rat
- Monkey (Rhesus) (Normal)-RsFPT
- Monkey (Cynomolgus) (Normal)-CyFPT
- Dog
- Multiple organ
- Gall bladder and bile duct
- Esophagogastric junction
Types/Disease
Cores
Cases

Cores:

72

CASES:

72

Core Diameter(mm):

2

Thickness(µm):

5

Row number:

8

Column number:

9

Tissue Array Type:

FFPE

Species:

Human

FMG08013f

$140.00

Description: Breast cancer with adjacent normal breast tissue array, including pathology grade, TNM and clinical stage, 72 cases/72 cores, replacing FMG08013e

Details: Breast carcinoma with adjacent normal breast tissue microarray, containing 63 cases of invasive carcinoma of no special type, 6 medullary carcinoma, 3 adjacent normal breast tissue, single core per case

Applications: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

Please Select Tissue Array Type:

Unstained

H&E

Tag:

72 Cores 72 Cases Breast Matched or Unmatched special price single core per case

Add To Cart

Outright purchase

Note

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

Specification sheet
Overlapping case
Download specifications

Legend:

Car-Cardia Eso-Fsophagus

Malignant(-)
Malignant(IB)
Malignant(IIA)
Malignant(IIB)
Malignant(IIIA)
Malignant(IIIB)
NAT(-)
_ki

TISSUE ARRAYS
FMG08013f

	1	2	3	4	5	6	7	8	9
A	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
B	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
C	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
D	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
E	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
F	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
G	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
H	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	_ki

FMG08013f

Age:
Sex:
Organ/Anatomic Site:
Pathology diagnosis:
Grade:
TNM:
Stage:
Tissue ID.:
Type:

Pos	No.	Age	Sex	Organ/Anatomic Site	Pathology diagnosis	Grade	TNM	Stage	Type	Ki-67	ER	PR	Her-2
A1	1	43	F	Breast	Invasive carcinoma of no special type with necrosis	1	T3N0M0	IIB	Malignant	-	-	0.1	-
A2	2	75	F	Breast	Invasive carcinoma of no special type	1	T3N1M0	IIIA	Malignant	-	++90%	++80%	-
A3	3	32	F	Breast	Invasive carcinoma of no special type	1--2	T3N1M0	IIB	Malignant	+15%	+80%	++70%	-
A4	4	55	F	Breast	Invasive carcinoma of no special type	1--2	T4N1M0	IIIB	Malignant	-	-	-	+30%
A5	5	52	F	Breast	Invasive carcinoma of no special type	1--2	T2N0M0	IIA	Malignant	+10%	++80%	++60%	+60%
A6	6	54	F	Breast	Invasive carcinoma of no special type	2	T2N1M0	IIB	Malignant	-	+10%	-	-
A7	7	48	F	Breast	Invasive carcinoma of no special type	2	T3N0M0	IIB	Malignant	-	++20%,+50%,（+）	++70%	-
A8	8	30	F	Breast	Invasive carcinoma of no special type	2	T2N0M0	IIA	Malignant	+12%	+40%	+<5%（-）	-
A9	9	54	F	Breast	Invasive carcinoma of no special type (sparse necrosis)	2	T3N0M0	IIB	Malignant	-	-	-	+40%
B1	10	55	F	Breast	Invasive carcinoma of no special type	2	T2N2M0	IIIA	Malignant	-	-	+<5%（-）	++70%
B2	11	29	F	Breast	Invasive carcinoma of no special type (sparse)	*	T2N0M0	IIA	Malignant	+20%	-	+5%	++60%
B3	12	87	F	Breast	Invasive carcinoma of no special type	2	T2N1M0	IIB	Malignant	-	-	-	-
B4	13	44	F	Breast	Invasive carcinoma of no special type (sparse)	*	T2N2M0	IIIA	Malignant	+10%	-	+5%	++10%,+20%,（++）
B5	14	42	F	Breast	Invasive carcinoma of no special type	2	T2N1M0	IIB	Malignant	+3%	-	+30%	-
B6	15	52	F	Breast	Invasive carcinoma of no special type	2	T2N1M0	IIB	Malignant	+6%	-	+5%	-
B7	16	42	F	Breast	Invasive carcinoma of no special type	2	T4N2M0	IIIB	Malignant	+20%	-	-	-
B8	17	55	F	Breast	Invasive carcinoma of no special type	2	T3N2M0	IIIB	Malignant	+10%	+++30%,++50%（+++）	+++70%	-
B9	18	43	F	Breast	Invasive carcinoma of no special type	2	T2N1M0	IIB	Malignant	++15%,+30%（++）	-	++20%,+50%（+）	-
C1	19	37	F	Breast	Invasive carcinoma of no special type	2	T2N1M0	IIb	Malignant	-	-	-	-
C2	20	38	F	Breast	Invasive carcinoma of no special type	2	T3N0M0	IIB	Malignant	++15%（+）	-	+20%	-
C3	21	48	F	Breast	Invasive carcinoma of no special type	2	T2N2M0	IIIA	Malignant	++80%	-	++5%,+60%（+）	-
C4	22	37	F	Breast	Invasive carcinoma of no special type	2	T2N2M0	IIIA	Malignant	+10%	+60%	++65%	-
C5	23	48	F	Breast	Invasive carcinoma of no special type (sparse)	*	T1N1M0	IB	Malignant	+8%	+55%	+60%	+10%
C6	24	46	F	Breast	Invasive carcinoma of no special type	2	T3N2M0	IIIA	Malignant	+8%	-	-	+++80%
C7	25	68	F	Breast	Invasive carcinoma of no special type	2	T3N0M0	IIB	Malignant	-	+70%	-	-
C8	26	51	F	Breast	Invasive carcinoma of no special type with necrosis	2	T2N2M0	IIIA	Malignant	+15%	+++90%	++40%,+40%（++）	-
C9	27	52	F	Breast	Invasive carcinoma of no special type	2	T4N1M0	IIIB	Malignant	+5%	-	+40%	+30%
D1	28	52	F	Breast	Invasive carcinoma of no special type	2	T3N1M0	IIIA	Malignant	-	-	-	-
D2	29	42	F	Breast	Invasive carcinoma of no special type	2	T2N0M0	IIA	Malignant	+20%	-	+5%	-
D3	30	41	F	Breast	Invasive carcinoma of no special type (sparse necrosis)	2	T2N0M0	IIA	Malignant	+20%	+60%	+40%	-
D4	31	47	F	Breast	Invasive carcinoma of no special type	2	T4N1M0	IIIB	Malignant	+10%	++70%	+30%	-
D5	32	32	F	Breast	Invasive carcinoma of no special type with necrosis	2	T4N1M0	IIIB	Malignant	+25%	-	-	++80%
D6	33	32	F	Breast	Invasive carcinoma of no special type	2	T2N1M0	IIB	Malignant	+10%	-	+30%	++70%
D7	34	53	F	Breast	Invasive carcinoma of no special type	2--3	T2N2M0	IIIA	Malignant	+30%	-	-	-
D8	35	59	F	Breast	Invasive carcinoma of no special type	2--3	T2N0M0	IIA	Malignant	+20%	-	-	-
D9	36	38	F	Breast	Invasive carcinoma of no special type (sparse)	*	T2N0M0	IIA	Malignant	-	-	-	*
E1	37	51	F	Breast	Invasive carcinoma of no special type with necrosis	3	T3N1M0	IIIA	Malignant	+25%	-	-	+80%
E2	38	58	F	Breast	Invasive carcinoma of no special type with necrosis	3	T2N1M0	IIA	Malignant	+40%	-	-	-
E3	39	52	F	Breast	Invasive carcinoma of no special type	3	T3N2M0	IIIB	Malignant	-	-	-	+10%
E4	40	48	F	Breast	Invasive carcinoma of no special type (sparse necrosis)	3	T3N0M0	IIB	Malignant	++35%	-	-	+5%
E5	41	55	F	Breast	Invasive carcinoma of no special type (sparse)	3	T3N0M0	IIB	Malignant	+10%	-	-	+10%
E6	42	60	F	Breast	Invasive carcinoma of no special type	3	T2N2M0	IIIA	Malignant	+40%	-	+60%	+++80%
E7	43	48	F	Breast	Invasive carcinoma of no special type	3	T4N2M0	IIIB	Malignant	+30%	+++90%	+<5%（+）	-
E8	44	39	F	Breast	Invasive carcinoma of no special type	3	T4N2M0	IIIB	Malignant	++80%	-	+80%	-
E9	45	61	F	Breast	Invasive carcinoma of no special type	3	T3N1M0	IIIA	Malignant	+5%	+++60%,++30%（+++）	++10%,+60%（+）	-
F1	46	37	F	Breast	Invasive carcinoma of no special type	3	T3N0M0	IIB	Malignant	+8%	-	-	-
F2	47	73	F	Breast	Invasive carcinoma of no special type	3	T4N0M0	IIIB	Malignant	+20%	-	-	+++80%
F3	48	71	F	Breast	Invasive carcinoma of no special type	3	T2N1M0	IIB	Malignant	+18%	-	+20%	+5%
F4	49	44	F	Breast	Invasive carcinoma of no special type	3	T2N2M0	IIIA	Malignant	++30%	++80%	+++50%,++40%（+++）	++70%
F5	50	50	F	Breast	Invasive carcinoma of no special type	3	T2N0M0	IIA	Malignant	+40%	++40%,+40%（++）	-	-
F6	51	49	F	Breast	Invasive carcinoma of no special type	3	T2N2M0	IIIA	Malignant	+5%	+++80%	+++20%,++60%（++）	-
F7	52	38	F	Breast	Invasive carcinoma of no special type	3	T2N0M0	IIA	Malignant	+20%	++30%,+40%（++）	++15%,+40%（+）	+10%
F8	53	38	F	Breast	Invasive carcinoma of no special type (sparse necrosis)	3	T3N1M0	IIIA	Malignant	+30%	-	-	-
F9	54	50	F	Breast	Invasive carcinoma of no special type	3	T2N1M0	IIB	Malignant	++20%	-	+60%	+20%
G1	55	52	F	Breast	Invasive carcinoma of no special type	3	T2N0M0	IIA	Malignant	+8%	+35%	+20%	-
G2	56	54	F	Breast	Invasive carcinoma of no special type (sparse necrosis)	3	T2N2M0	IIIA	Malignant	+30%	-	-	-
G3	57	56	F	Breast	Invasive carcinoma of no special type	3	T2N2M0	IIIA	Malignant	+10%	-	-	++80%
G4	58	43	F	Breast	Invasive carcinoma of no special type	3	T1N1M0	IIA	Malignant	+5%	++80%	+30%	-
G5	59	48	F	Breast	Invasive carcinoma of no special type	3	-	-	Malignant	+5%	++20%,+50%（+）	++85%	-
G6	60	40	F	Breast	Invasive carcinoma of no special type	3	-	-	Malignant	+5%	-	++80%	-
G7	61	52	F	Breast	Invasive carcinoma of no special type	3	T1N1M0	IIA	Malignant	*	*	*	*
G8	62	56	F	Breast	Invasive carcinoma of no special type	3	T2N2M0	IIIA	Malignant	+15%	++20%,+40%（+）	+++70%,++20%（+++）	+++90%
G9	63	43	F	Breast	Invasive carcinoma of no special type	3	T2N0M0	IIA	Malignant	+20%	+8%	+30%	-
H1	64	49	F	Breast	Medullary carcinoma with necrosis	-	T2N2M0	IIIA	Malignant	+10%	-	-	-
H2	65	47	F	Breast	Medullary carcinoma	-	T2N2M0	IIA	Malignant	-	-	-	-
H3	66	57	F	Breast	Medullary carcinoma	-	T2N1M0	IIB	Malignant	+10%	-	-	+10%
H4	67	60	F	Breast	Medullary carcinoma	-	T3N2M0	IIIB	Malignant	-	-	-	-
H5	68	59	F	Breast	Medullary carcinoma	-	T3N0M0	IIB	Malignant	-	-	-	+++80%
H6	69	45	F	Breast	Medullary carcinoma	-	-	-	Malignant	+5%	-	-	-
H7	70	48	F	Breast	Adjacent normal breast tissue	-	-	-	NAT	N+3%	N+5%	N+8%	N-
H8	71	58	F	Breast	Adjacent normal breast tissue	-	-	-	NAT	N-	N-	N++40%	N-
H9	72	45	F	Breast	Adjacent normal breast tissue	-	-	-	NAT	N-	N+5%	N++60%	N-
_kidney cancera_

Find overlapping cases with this tissue array:

FMG08013f

File Format: .xlsx

Release Date: 2025-01-17 16:00:08
Download

	1	2	3	4	5	6	7	8	9
A	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
B	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
C	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
D	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
E	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
F	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
G	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
H	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	_ki

	1	2	3	4	5	6	7	8	9
A	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
B	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
C	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
D	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
E	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
F	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
G	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
H	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	_ki

	1	2	3	4	5	6	7	8	9
A	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
B	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
C	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
D	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
E	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
F	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
G	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
H	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	_ki